The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures.
Going to Cell & Gene Meeting on the Mesa?
Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 100+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 1,200 attendees – over 20% of which are C-level executives.
Related content
- Creating robust bioprocessing scale-down models [eBook]
- CellPreserve: our innovation could help prolong the lives of cancer patients [Insights]
- Let’s go! The new Catapult consortium is a brilliant boost for cell and gene therapy manufacturing [Insights]
- Bioinnovation: Business success from world-changing science [Expertise page]
